Miles Michael Glenn 4
4 · CANCER GENETICS, INC · Filed Feb 1, 2019
Insider Transaction Report
Form 4
Miles Michael Glenn
Chief Financial Officer
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2019-01-31$0.23/sh+150,000$34,500→ 150,000 total